Nanoviricides Inc (NNVC)
1.15
+0.01
(+0.88%)
USD |
NYAM |
Apr 24, 16:00
1.13
-0.02
(-1.74%)
After-Hours: 20:00
Nanoviricides Cash from Investing (TTM): -0.0756M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0756M |
| September 30, 2023 | -0.1155M |
| June 30, 2023 | -0.1517M |
| March 31, 2023 | -0.2245M |
| December 31, 2022 | -0.2045M |
| September 30, 2022 | -0.3445M |
| June 30, 2022 | -0.3243M |
| March 31, 2022 | -0.3336M |
| December 31, 2021 | -0.4049M |
| September 30, 2021 | -0.2281M |
| June 30, 2021 | -0.2388M |
| March 31, 2021 | -0.1586M |
| December 31, 2020 | -0.0481M |
| September 30, 2020 | -0.0395M |
| June 30, 2020 | -0.0086M |
| March 31, 2020 | -0.0138M |
| December 31, 2019 | -0.0204M |
| September 30, 2019 | -0.0407M |
| June 30, 2019 | -0.0738M |
| March 31, 2019 | -0.0808M |
| December 31, 2018 | -0.2068M |
| September 30, 2018 | -0.2486M |
| June 30, 2018 | -0.2418M |
| March 31, 2018 | -0.2716M |
| December 31, 2017 | -0.2331M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.171M |
| June 30, 2017 | -0.165M |
| March 31, 2017 | -0.1707M |
| December 31, 2016 | -0.1373M |
| September 30, 2016 | -0.1671M |
| June 30, 2016 | -0.4764M |
| March 31, 2016 | -1.620M |
| December 31, 2015 | -0.8103M |
| September 30, 2015 | -5.531M |
| June 30, 2015 | -5.760M |
| March 31, 2015 | -5.177M |
| December 31, 2014 | -7.186M |
| September 30, 2014 | -2.520M |
| June 30, 2014 | -5.231M |
| March 31, 2014 | -4.683M |
| December 31, 2013 | -4.423M |
| September 30, 2013 | -4.339M |
| June 30, 2013 | -1.065M |
| March 31, 2013 | -1.00M |
| December 31, 2012 | -0.0112M |
| September 30, 2012 | -0.0295M |
| June 30, 2012 | -0.0586M |
| March 31, 2012 | -0.0818M |
| December 31, 2011 | -0.1169M |
| September 30, 2011 | -0.0986M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.4049M
Minimum
Dec 2021
-0.0086M
Maximum
Jun 2020
-0.1605M
Average
-0.1517M
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
| Gilead Sciences Inc | -2.265B |
| NovaBay Pharmaceuticals Inc | -0.019M |
| Palatin Technologies Inc | 9.293M |
| iBio Inc | 8.285M |
| Theriva Biologics Inc | -0.202M |